CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O
Rewrite: DRUGMATRIX assay uses AB-MECA as a ligand for Adenosine A2A radioligand binding. The assay focuses on a single protein target and uses HEK293 cells and membrane fraction in vitro for binding analysis. Does the molecule work for this test?